XNAS · Healthcare · Diagnostics & Research
Veracyte Inc is a genomic diagnostics company. The group empowers clinicians with the insights necessary to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. It offers tests for prostate cancer (Decipher Prostate), thyroid cancer (Afirma), breast cancer (Prosigna), and bladder cancer (Decipher Bladder).
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-05 | Q1 2026 | 0.31 | 0.52 | +67.74% | $139.1M | ✅ Beat | +12.22% | +19.99% | — |
| 2026-02-25 | Q4 2025 | 0.36 | 0.53 | +47.22% | $140.6M | ✅ Beat | +3.58% | +1.54% | -15.99% |
| 2025-11-04 |
| Q3 2025 |
| 0.27 |
| 0.51 |
| +88.89% |
| $131.9M |
| ✅ Beat |
| — |
| — |
| — |
| 2025-08-06 | Q2 2025 | 0.25 | 0.44 | +76.00% | $130.2M | ✅ Beat | +5.92% | +27.99% | +35.29% |
| 2025-02-24 | Q4 2024 | 0.26 | 0.36 | +38.46% | $118.6M | ✅ Beat | -14.99% | -14.74% | -21.11% |
| 2024-11-06 | Q3 2024 | 0.17 | 0.33 | +94.12% | $115.9M | ✅ Beat | +2.05% | +8.04% | +20.61% |
| 2024-08-06 | Q2 2024 | -0.03 | 0.30 | +1100.00% | $114.4M | ✅ Beat | +23.97% | +49.18% | +36.43% |
| 2024-05-07 | Q1 2024 | -0.17 | -0.02 | +88.24% | $96.8M | ✅ Beat | -4.33% | +9.46% | +1.81% |
Showing last 8 quarters.